|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Pfizer Inc. (PFE) to Cut 600 Jobs as Lipitor Sales Decline
12/19/2012 7:29:11 AM
Pfizer Inc. (PFE), the company that lost its patent a year ago on the top-selling drug Lipitor, is firing almost 20 percent of its roughly 3,000-person sales force for primary-care drugs, said a person familiar with the matter. The cuts, about 600 positions, are to begin this month and are part of the New York-based company’s continuing effort to lower costs, said the person, who asked not to be named because they weren’t authorized to discuss the matter publicly. Pfizer has been cutting expenses under Chief Executive Officer Ian Read as it seeks to reposition itself after the loss of Lipitor, the cholesterol-lowering medicine that generated $9.6 billion in revenue in 2011. Read has said he’s refocusing the company to bring new drugs to market as it continues to integrate a decade’s worth of acquisitions. “As part of our strategy to allocate our resources, investments and people to the areas that best serve our patients and customers, we continually evaluate how we can be more efficient and effective,” Mackay Jimeson, a Pfizer spokesman, wrote in an e-mail. “As a result, we are making changes in some segments of our field force to better match the future needs of the business.” Pfizer rose 1.1 percent to $25.64 at 4 p.m. New York time. The stock is up 18 percent since the start of the year. Primary-care drugs make up Pfizer’s top-selling products, and include the erectile dysfunction pill Viagra, pain therapy Lyrica and the arthritis treatment Celebrex.
|
|
|
|
|
|
|
|
|
|
|